Invention Grant
- Patent Title: EBV antigen specific T-cell receptor and use thereof
-
Application No.: US15974647Application Date: 2018-05-08
-
Publication No.: US10251936B2Publication Date: 2019-04-09
- Inventor: Tai Gyu Kim , Hyun Il Cho
- Applicant: THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY—ACADEMIC COOPERATION FOUNDATION
- Applicant Address: KR Seoul
- Assignee: The Catholic Unviersity of Korea Industry-Academic Cooperation Foundation
- Current Assignee: The Catholic Unviersity of Korea Industry-Academic Cooperation Foundation
- Current Assignee Address: KR Seoul
- Agency: Leydig, Voit & Mayer, Ltd.
- Priority: KR10-2015-0123823 20150901
- Main IPC: A61K38/17
- IPC: A61K38/17 ; C07K14/70 ; C07K14/725
Abstract:
The present invention relates to an EBV antigen specific T-cell receptor and the use thereof. Specifically, the present invention provides T cells specific for LMP1 of EBV using a T-cell receptor which is highly specific for specific epitopes derived from an EBV antigen, LMP1. In addition, the EBV antigen specific T-cell can be used in the prevention or treatment of EBV-associated diseases.
Public/Granted literature
- US20180326003A1 EBV ANTIGEN SPECIFIC T-CELL RECEPTOR AND USE THEREOF Public/Granted day:2018-11-15
Information query
IPC分类:
